Clinical Trials Directory

Trials / Completed

CompletedNCT02288715

Relationship of Cerebral Perfusion Pressure Variability to Sepsis-associated Encephalopathy

Status
Completed
Phase
Study type
Observational
Enrollment
110 (actual)
Sponsor
Kang Yan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to evaluate whether variability of CPP (cerebral perfusion pressure) is related to sepsis-associated encephalopathy and outcomes of patients with sepsis.

Detailed description

Encephalopathy is a common complication of sepsis, impaired cerebrovascular autoregulation (AR) in patients with sepsis is considered related to Sepsis-associated encephalopathy (SAE). As AR is important in stabilizing the cerebral perfusion pressure, whether greater variability of CPP is related to SAE and mortality or not remains unclear. We conduct this study to evaluate the relationship between them.

Conditions

Interventions

TypeNameDescription
OTHERno interventions

Timeline

Start date
2014-05-01
Primary completion
2015-03-01
Completion
2017-03-01
First posted
2014-11-11
Last updated
2017-11-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02288715. Inclusion in this directory is not an endorsement.